socaltech | Shared With: Everyone - Aug 08 2006 | cabrellis, cancer, lung, domain, associates, venture, capital, vc, investment, funding, anthracycline, socaltechSan Diego-based Cabrellis Pharmaceuticals, which is developing treatments for cancer, said Monday that it has raised $27.5M in a Series A funding round. Funding came from Domain Associates, Forward Ventures, Lilly Ventures, Novo A/S, ProQuest Investments,
- socaltech | Shared With: Everyone - Oct 06 2006 | cabrellis, vp, regulatory, affairs, novartis, cancer, vice, president, socaltech
San Diego-based Cabrellis Pharmaceuticals has named a new Vice President of Regulatory Affairs and Development Operations. Cabrellis said earlier this week that Tracy Lawhon has been appointed to the position, joining the firm from Novartis Pharmaceutical
ShareViewed: 1 Time
Send socaltech a friend request or a personal message instead.